Hostname: page-component-76fb5796d-45l2p Total loading time: 0 Render date: 2024-04-30T03:04:02.826Z Has data issue: false hasContentIssue false
  • English
  • Français

Mixed Amphetamine Salts Extended Release for the Treatment of ADHD

Published online by Cambridge University Press:  07 November 2014

Joseph Biederman
Get access Rights & Permissions [Opens in a new window]

Extract

Attention-deficit/hyperactivity disorder (ADHD) is widely recognized as one of the most common psychiatric disorders initially diagnosed and treated in childhood; however, it is less widely recognized as a disorder that often persists into adolescence and adulthood. In recent years, there has been increased awareness that adult ADHD is marked by significant impulsivity and impairments of attention and executive function, symptoms that can be linked to, personal, social, and professional dysfunction. Clinicians are increasingly recognizing adult ADHD as a disorder linked to considerable dysfunction and distress, warranting appropriate pharmacologic treatment.

Psychostimulants, such as amphetamines and methylphenidate, are recommended as first-line pharmacotherapeutic agents for the management of ADHD in children, adolescents, and adults. Because most research on psychostimulant use has involved pediatric ADHD patients, little is known about the safety and efficacy of these agents in adult ADHD.

Type
Introduction
Information
CNS Spectrums , Volume 10 , Issue S20: Mixed Amphetamine Salts Extended Release for the Treatment of ADHD in Adults: Current Evidence , December 2005 , pp. 5
Copyright
Copyright © Cambridge University Press 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Weiss, G, Hechtman, L, Milroy, T, Perlman, T. Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Adolesc Psychiatry. 1985;24(2):211–220.CrossRefGoogle Scholar
2. Biederman, J, Faraone, S, Milberger, S, et al. Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1996;35(3):343–351.CrossRefGoogle ScholarPubMed
3. Wilens, TE, Faraone, SV, Biederman, J.Attention-deficit/hyperactivity disorder in adults. JAMA. 2004;292(5):619–623.CrossRefGoogle ScholarPubMed
4. Barkley, RA. Major life activity and health outcomes associated with attentiondeficit/hyperactivity disorder. J Clin Psychiatry. 2002;63(suppl 12):10–15.Google Scholar
5. Faraone, SV, Biederman, J.A controlled study of functional impairments in 500 ADHD adults. Presented at: 157th Annual Meeting of the American Psychiatric Association; May 1–6, 2004; New York, NY.Google Scholar
6. Greenhill, LL, Pliszka, S, Dulcan, MK, et al; American Academy of Child and Adolescent Psychiatry. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2002;41(suppl):26S–49S.CrossRefGoogle ScholarPubMed